Speaker Profile
CEO, Acurion
Biography
As CEO of Acurion, Inc., Rick leads a seasoned and diverse leadership team, guiding the
company through key regulatory milestones and into commercial growth. Rick brings a strong track record of scaling both nonprofit and for-profit
organizations.
Prior to Acurion, Rick was a Partner at First Capital Accelerator, where he focused on
fundraising, evaluating investment opportunities, and supporting the growth of early -
stage portfolio companies. From 2010 to 2024, he served as Senior Vice President and
Chief Business Officer at Biocom California. In this role, he was instrumental in driving
statewide expansion, business development, and strategic partnerships, while
overseeing the Biocom Purchasing Group. He also established Biocom’s presence in Los
Angeles and the Bay Area and served as the organization’s first Executive Director in
San Diego. In his various roles at Biocom he has helped hundreds of small and mid-sized
life science companies advance their missions.
Talk
Making Precision Medicine Real for Patients Worldwide Using AI
Acurion is transforming frontline cancer diagnosis with OncoGaze™, an AI platform that delivers NGS-equivalent genomic insights instantly from a digital biopsy—removing the cost and delays of traditional sequencing and expanding access to precision oncology worldwide.
AI and Data Sciences Showcase:
Acurion
Acurion is transforming frontline cancer diagnosis with OncoGaze™, an AI platform that delivers NGS-equivalent genomic insights instantly from a digital biopsy—removing the cost and delays of traditional sequencing and expanding access to precision oncology worldwide.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
